Ed has been instrumental in Catalyst's growth and evolution as a company. We are pioneering a new drug discovery approach to disease, and Ed has provided exceptional leadership for the rapid development of technology and programs that align our milestones with our vision.
These investments are aligned with our extensive queue of projects that are scheduled to come on line between now and 2008, bringing significant new supplies of energy to U.S. and global markets.